ARCHIVES

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

This article is from The Cancer Letter archive.

Vol. 21 No. 23 | June 9, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Clarifies P01 Grant Application Dates

September 13, 1996

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976